Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC-ICP-MS

Journal of Analytical Atomic Spectrometry

Volumn 18, Issue 8, 2003, Pages 884-890

  Vacchina, Véronique ^a   Torti, Laura ^b   Allievi, Cecilia ^b   Lobinski, Ryszard ^c,d  

^a Laboratoire Ultra Traces An4alyse Aquitaine   (France)

^b Novuspharma SpA   (Italy)

^c Laboratoire de Chimie Analytique Bio Inorganique et Environnement UMR 5034   (France)

^d WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POSITIVE IONS; ULTRAFILTRATION;

CATION EXCHANGE;

INDUCTIVELY COUPLED PLASMA;

EID: 0042973042     PISSN: 02679477     EISSN: None     Source Type: Journal    
DOI: 10.1039/b302241b     Document Type: Article

References (21)

1. R. R. Barefoot, J. Chromatogr., B: Biomed. Appl., 2001, 751, 205-211.
2. T. J. Einhäuser, M. Galanski and B. K. Keppler, J. Anal. At. Spectrom., 1996, 11, 747-750.
3. A. R. Timerbaev, A. Kung and B. K. Keppler, J. Chromatogr., 2002, 9-45, 25-44.
4. J. Welink, B. Pechstein and W. J. F. Van der Vijsh, J. Chromatogr., B: Biomed. Appl., 1996, 675, 107-111.
5. W. W. Bullen, L. D. Andress, L. R. Whitfield, M. L. Welch and R. A. Newman, Cancer Chemother. Pharmacol., 1992, 30, 193-198.
6. A. Andersson and H. Ehrsson, J. Chromatogr., B: Biomed. Appl., 1994, 652, 203-210.
7. G. K. Poon, F. I. Raynaud, P. Mistry, D. E. Odell, L. R. Kelland, K. R. Harrap, C. F. J. Barnard and B. A. Murrer, J. Chromatogr., A, 1995, 712, 61-66.
8. R. B. Burns, R. W. Burton, S. P. Albon and L. Embree, J. Pharm. Biomed. Anal., 1996, 14, 367-372.
9. F. R. Luo, T. Y. Yen, S. D. Wyrick and S. G. Chaney, J. Chromatogr., B: Biomed. Appl., 1999, 724, 345-356.
10. P. F. Dodion, D. de Valeria, N. Crespeigne, J. D. Kantrowitz, M. Piccart, F. Wery, J. Kerger, M. J. Ergorin, A. Forrest and N. R. Bachur, Ann. Oncol., 1991, 2, 589-596.
11. S. Kishimoto, T. Noguchi, T. Yamaoka, S. Fukushima and Y. Takeuchi, Biol. Pharm. Bull., 2000, 23, 637-640.
12. M. Verschraagen, K. Van der Born, T. H. U. Zwiers and W. J. F. Van der Vijgh J. Chromatogr., B: Biomed. Appl., 2002, 772, 273-281.
13. I. Ikeuchi, I. Fujisaka, Y. Suzuki, K. Fujimoto and T. Kitagawa, Biomed. Res. Trace Elem., 1993, 4, 49-50.
14. W. R. L. Cairns, L. Ebdon and S. Hill, Fresenius J. Anal. Chem., 1996, 355, 202-208.
15. P. J. Galletis, J. L. Carr, J. W. Paxton and M. J. McKeage, J. Anal. At. Spectrom., 1999, 14, 953-956.
16. J. Szpunar, A. Makarov,T. Pieper, B. K. Keppler and R. Lobinski, Anal. Chim. Acta, 1999, 387, 135-144.
17. T. Servidei, C. Ferlini, A. Riccardi, D. Meco, G. Scambia, G. Segni, C. Manzotti and R. Riccardi, Eur. J. Cancer, 2001, 37, 930-938.
18. V. P. Shah, K. K. Midha, J. W. A. Hill, M. Howard, J. D. Hulse, I. McGilveray, G. McKay, K. J. Miller, R. N. Patnaik, M. L. Powell, A. Tonelli, C. T. Viswanathan and A. Yacobi, Pharm. Res., 2000, 17, 1551-1557.
19. J. L. Todoli, S. Maestre, A. Canals and V. Hernandis, Fresenius J. Anal. Chem., 2000, 368, 773-779.
20. J. Mierzwa, R. Brandt, J. A. C. Broekaert, P. Tschöpel and G. Tölg, Spectrochim. Acta, Part B, 1996, 51, 117-126.
21. X. Tang, J. W. Hayes II, L. Schroder, W. Cacini, J. Dorsey, R. C Elder and K. Tepperman, Met. Based Drugs, 1997, 4, 97-109.